Medicine guide
VANFLYTA 17
As listed in the register: VANFLYTA 17,7 mg, comprimé pelliculé
comprimé pelliculé
- Prescription only
- Active substance
- Dichlorhydrate De Quizartinib
- Made by
- DAIICHI SANKYO EUROPE (ALLEMAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | DAIICHI SANKYO EUROPE (ALLEMAGNE) |
|---|---|
| Active substance | Dichlorhydrate De Quizartinib |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en maladie du sang |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1768 |
| Name in the register | VANFLYTA 17,7 mg, comprimé pelliculé |
| Packs | 28 plaquettes aluminium de 1 comprimé |
| CIS | 69293541 |
| CIP13 | 3400930282632 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.